Kobo Biotech (BOM:531541) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Kobo Biotech FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Kobo Biotech's Free Cash Flow for the three months ended in Dec. 2023 was ₹0.00 Mil. Kobo Biotech's Revenue for the three months ended in Dec. 2023 was ₹0.00 Mil. Therefore, Kobo Biotech's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Kobo Biotech's current FCF Yield % is 8.09%.

The historical rank and industry rank for Kobo Biotech's FCF Margin % or its related term are showing as below:

During the past 13 years, the highest FCF Margin % of Kobo Biotech was 66.49%. The lowest was 11.11%. And the median was 38.80%.

BOM:531541's FCF Margin % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.06
* Ranked among companies with meaningful FCF Margin % only.

Kobo Biotech FCF Margin % Historical Data

The historical data trend for Kobo Biotech's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kobo Biotech FCF Margin % Chart

Kobo Biotech Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

FCF Margin %

Get a 7-Day Free Trial

Kobo Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Kobo Biotech's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Kobo Biotech's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kobo Biotech's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kobo Biotech's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Kobo Biotech's FCF Margin % falls into.

Kobo Biotech FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Kobo Biotech's FCF Margin for the fiscal year that ended in Mar. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2023 )	/	Revenue (A: Mar. 2023 )
	=	8.746	/	0
	=	%

Kobo Biotech's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	0	/	0
	=	%

Kobo Biotech FCF Margin % Related Terms

Thank you for viewing the detailed overview of Kobo Biotech's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Kobo Biotech (BOM:531541) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kobo Biotech Ltd (BOM:531541) » Definitions » FCF Margin %

Traded in Other Exchanges

N/A

Address

Saki Vihar Road, Unit 104, HYDE Park, Opp. Ansa Industrial Estate, Andheri (East), Mumbai, MH, IND, 400 072

Website

http://www.kobobiotech.com

Kobo Biotech Ltd is a pharmaceutical company. Its business comprises the manufacturing and sale of APIs (Active Pharmaceutical Ingredients) based on fermentation technology and Intermediates to pharmaceutical companies.

Kobo Biotech (BOM:531541) Headlines

No Headlines